Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers

Journal of Alzheimer's Disease

Volumn 33, Issue 2, 2013, Pages 507-515

  Xu, Wei Li ^a,b   Caracciolo, Barbara ^a   Wang, Hui Xin ^a   Santoni, Giola ^a   Winblad, Bengt ^a   Fratiglioni, Laura ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

Amnestic mild cognitive impairment; APOE 4; dementia; hazard ratio; longitudinal study; mild cognitive impairment; other cognitive impairment no dementia

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AMNESIA; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RISK FACTOR;

EID: 84872434786     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121369     Document Type: Article

References (40)

1. DeMichele-Sweet MA, Sweet RA (2010) Genetics of psychosis in Alzheimer's disease: A review. J Alzheimers Dis 19, 761-780.
2. MahleyRW,Weisgraber KH, HuangY(2006) Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 103, 5644-5651.
3. Takeda M, Martinez R, Kudo T, Tanaka T, Okochi M, Tagami S, MoriharaT, Hashimoto R, CacabelosR(2010) Apolipoprotein E and central nervous system disorders: Reviews of clinical findings. Psychiatry Clin Neurosci 64, 592-607.
4. Shi J, Zhao CB, Vollmer TL, Tyry TM, Kuniyoshi SM (2008) APOEepsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 70, 185-190.
5. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach (2002) Natural history of mild cognitive impairment in older persons. Neurology 59, 198-205. (Pubitemid 34779177)
6. Petersen RC, Negash S (2008) Mild cognitive impairment: An overview. CNS Spectr 13, 45-53. (Pubitemid 351224282)
7. Caracciolo B, Palmer K, Monastero R, Winblad B, Backman L, Fratiglioni L (2008) Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study. Neurology 70, 1778-1785. (Pubitemid 351653963)
8. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B International psychogeriatric association expert conference on mild cognitive impairment (2006) Mild cognitive impairment. Lancet 367, 1262-1270.
9. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF (2002) Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59, 1594-1599. (Pubitemid 35387068)
10. Boyle PA, Buchman AS, Wilson RS, Kelly JF, Bennett DA (2008) The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology 34, 43-49.
11. Tervo S, Kivipelto M, Hanninen T, Vanhanen M, Hallikainen M, Mannermaa A, Soininen H (2004) Incidence and risk factors for mild cognitive impairment: A population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 17, 196-203. (Pubitemid 38339747)
12. Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS,Markesbery WR (2006) Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 66, 828-832. (Pubitemid 43739755)
13. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH (2003) Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: Part 2. Arch Neurol 60, 1394-1399. (Pubitemid 37248800)
14. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, Boeve BF, Ivnik RJ, Petersen RC, Pankratz VS, Rocca WA (2006) Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment:Aprospective cohort study. Arch Neurol 63, 435-440.
15. Hsiung GY, Sadovnick AD, Feldman H (2004) Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: Data from the Canadian Study of Health and Aging. CMAJ 171, 863-867. (Pubitemid 39371553)
16. Aggarwal NT,Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA (2005) The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase 11, 3-7. (Pubitemid 40372854)
17. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273, 1274-1278.
18. Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC, Hayden K, Norton MC, Zandi PP, Toone L, West NA, Breitner JC (2006) Cache County Investigators Conversion to dementia from mild cognitive disorder: The cache county study. Neurology 67, 229-234. (Pubitemid 44305404)
19. Samaranch L, Cervantes S, Barabash A, Alonso A, Cabranes JA, Lamet I, Anćin I, Lorenzo E, Mart́inez-Lage P, Marcos A, Clariḿon J, Alcolea D, Lléo A, Blesa R, Ǵomez-Isla T, Pastor P (2009) The effect of MAPT H1 and APOE epsilon4 on transition from mild cognitive impairment to dementia. J Alzheimers Dis 22, 1065-1071.
20. DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, Jagust W (2004) Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 63, 220-227. (Pubitemid 38971118)
21. Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, SternY, Mayeux R (2005) Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol 62, 975-980. (Pubitemid 40973460)
22. Wang PN, Lirng JF, LinKN,Chang FC, LiuHC(2006) Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan. Neurobiol Aging 27, 1797-1806. (Pubitemid 44572576)
23. Qiu C, Kivipelto M, Aguero-Torres H,Winblad B, Fratiglioni L (2004) Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: Variation by age and sex. J Neurol Neurosurg Psychiatry 75, 828-833. (Pubitemid 38658502)
24. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Winblad B (1992) Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria. Arch Neurol 49, 927-932.
25. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, B?ackman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment. J Intern Med 256, 240-246. (Pubitemid 39222993)
26. Qiu C, Backman L,Winblad B, Aguero-Torres H, Fratiglioni L (2001) The influence of education on clinically diagnosed dementia incidence and mortality data from theKungsholmen Project. Arch Neurol 58, 2034-2039. (Pubitemid 33143982)
27. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L (2009) Uncontrolled diabetes increases the risk of Alzheimer's disease: A population-based cohort study. Diabetologia 52, 1031-1039.
28. XuW, Caracciolo B,Wang HX,Winblad B, Qiu C, Fratiglioni L (2010) Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 59, 1123-1131.
29. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L (2009) APOE-related mortality: Effect of dementia, cardiovascular disease and gender. Neurobiol Aging 30, 1545-1551.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
31. Xu W (2008) Diabetes mellitus and the risk of dementia: A population-based study. Karolinska Institutet. Accessed May 16, 2008. The frame of the thesis available at http://diss.kib.ki.se/2008/978-91-7357-516-4/
32. Laws SM, Hone E, Gandy S, Martins RN (2003) Expanding the association between the APOE gene and the risk of Alzheimer's disease: Possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84, 1215-1236. (Pubitemid 36343589)
33. Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C,Woodruff BK, Alexander GE, OsborneD (2007) Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol 64, 1306-1311. (Pubitemid 47403086)
34. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC (2004) Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The cache county study. Arch Gen Psychiatry 61, 518-524. (Pubitemid 38620851)
35. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
36. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van DuijnCM(1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278, 1349-1356. (Pubitemid 27449696)
37. Nicoll JA, Savva GM, Stewart J, Matthews FE, Brayne C, Ince P (1998) Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathol Appl Neurobiol 37, 285-294.
38. Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14, 55-61. (Pubitemid 26301547)
39. Noguchi S, Murakami K, Yamada N (1993) Apolipoprotein E genotype and Alzheimer's disease. Lancet 342, 737.
40. Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC (2004) Impact of APOE in mild cognitive impairment. Neurology 63, 1898-1901. (Pubitemid 39532387)